Clinical Trial Update: Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the safety and feasibility of natural killer cells in patients with chronic myeloid leukemia in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Chronic Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN